Back to search

Article

Identifying simultaneous inhibition of riboflavin metabolism and MEK as a novel therapeutic strategy for pancreatic cancer

2024-10-26

Abstract excerpt

Pancreatic ductal adenocarcinoma (PDAC) remains a formidable challenge with a survival rate of approximately 10%, largely due to the lack of diagnostic and therapeutic options. To identify novel therapeutic targets for PDAC, we previously developed a Drosophila melanogaster model, the ’ 4-hit ’ fly, which mimics the alterations in KRAS , TP53 , CDKN2A , and SMAD4 genes observed in PDAC. Through whole-body ge...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9beee056-4e37-518d-a661-1d386bd7dfc1
DOI
10.1101/2024.10.23.619807
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identifying simultaneous inhibition of riboflavin metabolism and MEK as a novel therapeutic strategy for pancreatic cancerDOI 10.1101/2024.10.23.619807
Select a neighboring publication to make it the new centre.